As of the latest Form 4 filed Jul 1, 2026.
What Axsome Therapeutics Inc insiders — officers, directors and 10% owners — have bought and sold in their own stock, straight from their SEC Form 4 filings. Values are shares × the reported transaction price where both are disclosed.
Buys plotted up, sells down; bar height is the disclosed dollar value (shares × reported price). Our Form 4 history is only complete from mid-2026, so early months are sparse — the series fills in as more filings land. Open-market purchases and sales only.
Newest filing first — the 32 most recent filings for AXSM.
| Filed | Trade date | Insider | Transaction | Shares | Price | Value | 10b5-1 | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-07-01 | 2026-07-01 | TABUTEAU HERRIOT Chief Executive Officer | SSale | −49.7K | $240.25 | $11.9M | Yes (planned) | Form 4 ↗ |
| 2026-07-01 | 2026-07-01 | TABUTEAU HERRIOT, Chief Executive Officer | MExercise | +49.7K | $4.95 | $246K | Yes (planned) | Form 4 ↗ |
| 2026-06-11 | 2026-06-11 | JEFFS ROGER Director | SSale | −286.00 | $249.12 | $71.2K | Yes (planned) | Form 4 ↗ |
| 2026-06-11 | 2026-06-10 | JEFFS ROGER, Director | SSale | −286.00 | $246.18 | $70.4K | Yes (planned) | Form 4 ↗ |
| 2026-06-10 | 2026-06-10 | Mahony Susan Director | SSale | −300.00 | $246.18 | $73.9K | Yes (planned) | Form 4 ↗ |
| 2026-06-10 | 2026-06-10 | Coleman Mark Director | SSale | −643.00 | $249.00 | $160K | Yes (planned) | Form 4 ↗ |
| 2026-06-10 | 2026-06-09 | Mahony Susan Director | SSale | −300.00 | $237.21 | $71.2K | Yes (planned) | Form 4 ↗ |
| 2026-06-10 | 2026-06-08 | JEFFS ROGER Director | MExercise | +1.43K | — | — | No | Form 4 ↗ |
| 2026-06-10 | 2026-06-08 | Saad Mark E Director | MExercise | +1.43K | — | — | No | Form 4 ↗ |
| 2026-06-10 | 2026-06-08 | Mahony Susan Director | MExercise | +1.43K | — | — | Yes (planned) | Form 4 ↗ |
| 2026-06-10 | 2026-06-08 | Coleman Mark Director | MExercise | +1.43K | — | — | Yes (planned) | Form 4 ↗ |
| 2026-06-09 | 2026-06-09 | TABUTEAU HERRIOT Chief Executive Officer | SSale | −49.7K | $241.01 | $12.0M | Yes (planned) | Form 4 ↗ |
| 2026-06-09 | 2026-06-09 | TABUTEAU HERRIOT, Chief Executive Officer | MExercise | +49.7K | $4.95 | $246K | Yes (planned) | Form 4 ↗ |
| 2026-06-09 | 2026-06-09 | Pizzie Nick Chief Financial Officer | SSale | −33.0K | $240.09 | $7.92M | Yes (planned) | Form 4 ↗ |
| 2026-06-09 | 2026-06-09 | Pizzie Nick, Chief Financial Officer | MExercise | +33.0K | $3.50 | $116K | Yes (planned) | Form 4 ↗ |
| 2026-06-02 | 2026-06-02 | Coleman Mark Director | SSale | −5.54K | $223.39 | $1.24M | Yes (planned) | Form 4 ↗ |
| 2026-06-02 | 2026-06-01 | Coleman Mark, Director | SSale | −6.00K | $230.30 | $1.38M | Yes (planned) | Form 4 ↗ |
| 2026-06-02 | 2026-05-29 | Coleman Mark, Director | SSale | −6.00K | $233.46 | $1.40M | Yes (planned) | Form 4 ↗ |
| 2026-05-05 | 2026-05-05 | Jacobson Mark L. Chief Operating Officer | SSale | −233.00 | $228.18 | $53.2K | Yes (planned) | Form 4 ↗ |
| 2026-05-05 | 2026-05-05 | Jacobson Mark L., Chief Operating Officer | MExercise | +233.00 | $12.95 | $3.02K | Yes (planned) | Form 4 ↗ |
| 2026-05-05 | 2026-05-04 | Jacobson Mark L., Chief Operating Officer | SSale | −4.52K | $227.94 | $1.03M | Yes (planned) | Form 4 ↗ |
| 2026-05-05 | 2026-05-04 | Jacobson Mark L., Chief Operating Officer | MExercise | +4.52K | $12.95 | $58.5K | Yes (planned) | Form 4 ↗ |
| 2026-04-23 | 2026-04-22 | Maizel Ari Chief Commercial Officer | SSale | −7.50K | $182.42 | $1.37M | Yes (planned) | Form 4 ↗ |
| 2026-04-23 | 2026-04-22 | Maizel Ari, Chief Commercial Officer | MExercise | +7.50K | $70.73 | $530K | Yes (planned) | Form 4 ↗ |
| 2026-02-27 | 2026-02-26 | Coleman Mark Director | SSale | −25.0K | $161.11 | $4.03M | Yes (planned) | Form 4 ↗ |
| 2026-02-27 | 2026-02-26 | Jacobson Mark L. Chief Operating Officer | SSale | −35.4K | $161.88 | $5.73M | Yes (planned) | Form 4 ↗ |
| 2026-02-27 | 2026-02-26 | Jacobson Mark L., Chief Operating Officer | MExercise | +35.4K | $2.85 | $101K | Yes (planned) | Form 4 ↗ |
| 2026-02-25 | 2026-02-23 | Coleman Mark Director | MExercise | +6.25K | $4.95 | $30.9K | No | Form 4 ↗ |
| 2026-02-23 | 2026-02-20 | Coleman Mark Director | MExercise | +12.5K | $4.95 | $61.8K | No | Form 4 ↗ |
| 2026-02-10 | 2026-02-10 | Coleman Mark Director | MExercise | +5.19K | $8.02 | $41.6K | No | Form 4 ↗ |
| 2026-02-02 | 2026-02-02 | TABUTEAU HERRIOT Chief Executive Officer | SSale | −32.4K | $185.60 | $6.02M | Yes (planned) | Form 4 ↗ |
| 2026-02-02 | 2026-02-02 | TABUTEAU HERRIOT, Chief Executive Officer | MExercise | +32.4K | $8.02 | $260K | Yes (planned) | Form 4 ↗ |
Insiders — a company’s officers, directors and holders of more than 10% of its stock — must report any trade in that stock to the SEC on a Form 4 within two business days. Each row here is one transaction from those filings.
The transaction code tells you what happened: Purchase (P) and Sale (S) are open-market trades — the ones markets watch most; Award (A) is a granted stock or unit, Option exercise (M) converts options into shares, and Gift (G) is a transfer for no consideration. Awards, exercises and gifts are largely compensation or administrative, not a directional bet.
One caveat on sales: many are made under a Rule 10b5-1 plan scheduled months in advance, so a sale is not automatically a bearish signal. Insider activity is a noisy input — read it alongside the filings, not on its own.
See also AXSM’s full analysis or the market-wide insider trading feed. The tabs above jump to AXSM’s other SEC data.
Source: SEC Form 4 filings for AXSM, parsed from EDGAR. Transaction prices are as reported in the filing — SEC public-domain data, not market quotes. Values are shares × reported price where both are disclosed; grants and gifts often carry no price. A delayed record of what insiders reported, not a live position or a recommendation.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.